Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026
Jupiter Neurosciences, Inc. (JUNS)
Company Research
Source: GlobeNewswire
Advancing FDA-Cleared Phase IIa Parkinson’s Program Targeting Neuroinflammation Dual-Path Strategy Combines Clinical Development with Revenue-Generating Nugevia™ JUPITER, FL, March 02, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system disorders, today announced that management will participate in the BIO Investment and Growth Summit 2026, hosted by the Biotechnology Innovation Organization (BIO), taking place March 2 to 3, 2026 in Miami Beach, Florida. The Company’s corporate presentation is scheduled for March 2, 2026, at 2:30 PM. At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. In November 2025, the U.S. Food and Drug Administration granted the Company’s Investigational New Drug (IND) application authorizing initiation of the trial. The IND clearance followed previously reported preclinical data demonstrating a nine-fo
Show less
Read more
Impact Snapshot
Event Time:
JUNS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JUNS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JUNS alerts
High impacting Jupiter Neurosciences, Inc. news events
Weekly update
A roundup of the hottest topics
JUNS
News
- Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 [Yahoo! Finance]Yahoo! Finance
- Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago [Yahoo! Finance]Yahoo! Finance
- Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-LagoGlobeNewswire
- Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial ExecutionGlobeNewswire
- Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 UsersGlobeNewswire